Rxcurve
HCPCS J2373 · per 20 MCG

Inj, immphentiv, 20 mcg

Products billed under this code include Immphentiv.

Payment limit per 20 MCG, by effective quarter, 3Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J2373

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Immphentiv Hikma Pharmaceuticals USA Inc. 00641-6245-10 250 $34.00
Immphentiv Hikma Pharmaceuticals USA Inc. 00641-6246-10 500 $68.00

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $0.136 +$0.012 20 MCG Inj, immphentiv, 20 mcg v1, posted September 17, 2026
3Q26 $0.124 −$0.005 20 MCG Inj, immphentiv, 20 mcg v1, posted September 15, 2026
2Q26 $0.129 −$0.007 20 MCG Inj, immphentiv, 20 mcg v1, posted September 15, 2026
1Q26 $0.136 −$0.005 20 MCG Inj, immphentiv, 20 mcg v1, posted September 15, 2026
4Q25 $0.141 +$0.012 20 MCG Inj, immphentiv, 20 mcg v1, posted September 8, 2026
3Q25 $0.129 −$0.009 20 MCG Inj, immphentiv, 20 mcg v1, posted March 10, 2026
2Q25 $0.138 −$0.001 20 MCG Inj, immphentiv, 20 mcg v1, posted March 10, 2026
1Q25 $0.139 −$0.014 20 MCG Inj, immphentiv, 20 mcg v1, posted December 19, 2025
4Q24 $0.153 −$0.059 20 MCG Inj, immphentiv, 20 mcg v1, posted June 11, 2025
3Q24 $0.212 – 20 MCG Inj, immphentiv, 20 mcg v1, posted June 11, 2025

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files